NS
DFTX

NBC Securities’s Definium Therapeutics DFTX Stock Holding History

NBC Securities’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.7K Hold
100
– – ﹤0.01% 2090
2026
Q1 		$1.89K Hold
100
– – ﹤0.01% 2331
2025
Q4 		$1.34K Hold
100
– – ﹤0.01% 2488
2025
Q3 		$1.18K Sell
100
-500
-83% -$4.66K ﹤0.01% 2510
2025
Q2 		$3K Hold
600
– – ﹤0.01% 2233
2025
Q1 		$3K Buy
+600
New +$4.3K ﹤0.01% 1976
2024
Q4 		– Sell
-600
Closed -$3K – 1770
2024
Q3 		$3K Hold
600
– – ﹤0.01% 1974
2024
Q2 		$4K Hold
600
– – ﹤0.01% 1895
2024
Q1 		$5K Buy
+600
New +$3.42K ﹤0.01% 1866

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

NBC Securities's DFTX Position: Q2 2026 in Review

NBC Securities held its Definium Therapeutics (DFTX) position steady in Q2 2026 at 100 shares worth $4.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2090.

NBC Securities first reported a position in DFTX in Q1 2024 and has held it in 9 quarters since. The position peaked at $5K in Q1 2024. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • NBC Securities held 100 shares of Definium Therapeutics worth $4.7K as of Q2 2026.
  • NBC Securities left its Definium Therapeutics share count unchanged in Q2 2026.
  • Definium Therapeutics made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #2090 holding.
  • NBC Securities first reported a position in Definium Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • NBC Securities's Definium Therapeutics position peaked at $5K in Q1 2024.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.